Literature DB >> 18505740

The role of smoking in abdominal aortic aneurysm development.

Stephen A Badger1, Mark E O'Donnell, Muhammed A Sharif, Cyril McMaster, Ian S Young, Chee V Soong.   

Abstract

Abdominal aortic aneurysm is common. The aim of this study was to assess the effect of smoking on prevalence and management. Patients attending the vascular unit and appropriate controls were prospectively recruited. A smoking history revealed tobacco exposure in pack years. Serum cotinine was assessed biochemically. Independent risk factors were statistically determined. In all, 202 (186 men) patients were recruited, with 202 (197 men) controls. A total of 69 patients tested positive for cotinine, whereas 39 controls were positive (P = .001). Smoking and ischemic heart disease were significant predictors for aneurysm prevalence. Cardiac disease emerged as a more important predictor than smoking in symptomatic patients. In noncardiac patients, smoking and hypercholesterolemia were significant risk factors. Smoking is a significant predictor for aneurysm development. In high-risk patients, the cardiac disease process is the most important factor, with control of this imperative. However, in noncardiac patients, smoking cessation and lipid-lowering therapy are crucial.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505740     DOI: 10.1177/0003319708318380

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

Review 1.  Pharmacological treatment of vascular risk factors for reducing mortality and cardiovascular events in patients with abdominal aortic aneurysm.

Authors:  Lindsay Robertson; Edmond Atallah; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2017-01-12

2.  Screening for Prevalence of Abdominal Aortic Aneurysm During Transthoracic Echocardiography in Patient With Significant Coronary Artery Disease.

Authors:  Pravesh Vishwakarma; Panduranga Patwari; Akshyaya Pradhan; Monika Bhandari; Rishi Sethi; Sharad Chandra; Gaurav Chaudhary; Akhil Sharma; Sudhanshu Kumar Dwivedi; Varun Shankar Narain
Journal:  Cardiol Res       Date:  2021-08-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.